drugset / Trial / NCT01437943
Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effect of a short-term aliskiren treatment on kidney metabolism in patients at high risk for developing kidney dysfunction (i.e. kidney transplanted patients). The study is aimed at evaluating if any effect on kidney metabolism \[using proton MR Spectroscopy(1H-MRS)\] can be detected following a 6 months treatment with aliskiren regardless of its anti-hypertensive role. 1H-MRS can record a larger number of chemical species (up to 40) in the kidney, and monitor changes according to the pathologic state and health of the transplanted kidney.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-01
- Completion
- 2012-01
Outcome
Outcome not reported
Stopped: “Novartis has have decided to terminate all clinical investigator-initiated research projects involving aliskiren”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aliskiren | Small molecule | 150 mg | Oral |